CollPlant Biotechnologies (CLGN) Acquisitions (2020 - 2021)
CollPlant Biotechnologies' (CLGN) quarterly Acquisitions came in at $8.3 million in Q3 2021, up 506.3% YoY from $1.4 million in Q3 2020, and up 469.36% on a QoQ basis from -$2.2 million in Q2 2021.
CollPlant Biotechnologies (CLGN) Acquisitions (2020 - 2021) Analysis & Trends
CollPlant Biotechnologies (CLGN) has 2 years of Acquisitions data on file, last reported at $8.3 million in Q3 2021.
- Quarterly Acquisitions rose 506.3% year-over-year to $8.3 million in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $24.1 million (changed N/A YoY) and the FY2020 annual result came in at $3.3 million, down 12.08% from the prior year.
- Acquisitions improved to $8.3 million in Q3 2021, from -$2.2 million in the prior quarter.
- In the past five years, Acquisitions ranged from a high of $19.7 million in Q1 2021 to a low of -$2.2 million in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.41 Bn | 131.56 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.14 Bn | 78.15 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.52 Bn | 60.34 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | - |
| 10 | CollPlant Biotechnologies | 4.23 Mn | 4.23 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 8.27 Mn |
| Jun 30, 2021 | -2.24 Mn |
| Mar 31, 2021 | 19.72 Mn |
| Dec 31, 2020 | -1.70 Mn |
| Sep 30, 2020 | 1.36 Mn |
| Jun 30, 2020 | -1.94 Mn |
| Mar 31, 2020 | 5.61 Mn |